Overview
I am a pathologist specializing in cytopathology and surgical pathology. I diagnose diseases through integrating clinical history and studying patient samples under the microscope. As a cytopathologist, I perform fine needle aspiration biopsies in our clinic. I serve as Chief of the Head and Neck Service, and Director of the Duke Pathology Communications Group.
My research interests focus on the pathology of the head and neck and endocrine systems, with particular interest in thyroid nodules and neoplasia, and ultrasound-guided FNA. I work with a multidisciplinary team to improve our understanding of disease. I also focus on novel applications of social media for physicians and medical education.
Current Appointments & Affiliations
Adjunct Professor in the Department of Pathology
·
2024 - Present
Pathology,
Clinical Science Departments
Member of the Duke Cancer Institute
·
2017 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
The 1000 Mitoses Project: A Consensus-Based International Collaborative Study on Mitotic Figures Classification.
Journal Article Int J Surg Pathol · December 2024 Introduction. The identification of mitotic figures is essential for the diagnosis, grading, and classification of various different tumors. Despite its importance, there is a paucity of literature reporting the consistency in interpreting mitotic figures ... Full text Link to item CiteIs Social Media Here to Stay?: Survey Results Indicate Increasing Pathologist Interest and Engagement Over Time.
Journal Article Archives of pathology & laboratory medicine · October 2024 Context.—Social media has become widely adopted by pathologists and other physicians for professional purposes. While engagement has likely increased over time, there remain few concrete data regarding attitudes toward its use.Objective.— ... Full text CiteThe negative outlook: Long-term follow up of ThyroSeq negative and low-risk nodules.
Journal Article Cancer Cytopathol · October 2024 BACKGROUND: Molecular testing of thyroid nodules is an essential tool to help risk stratify nodules with indeterminate cytology. Although ThyroSeq testing has been around for over a decade, there is a paucity of long-term follow-up data on cytologically in ... Full text Link to item CiteRecent Grants
Computational tumor phenotyping to interrogate treatment resistance and immune dysregulation in head and neck cancer
ResearchCo Investigator · Awarded by National Institutes of Health · 2024 - 2029Rapid 3D whole-slide microscope digitization for thick cytopathology slides
ResearchPrincipal Investigator · Awarded by Ramona Optics, Inc. · 2020 - 2023View All Grants
Education, Training & Certifications
Duke University, School of Medicine ·
2009
M.D.